Greater Manchester announces weight loss medication study

A partnership to better understand weight loss medication has been announced at the Government’s International Investment Summit.

(c) Michal Jarmoluk/Pixabay

(c) Michal Jarmoluk/Pixabay

The five-year study between Health Innovation Manchester and US pharmaceutical company Lilly will evaluate the real-world effectiveness of tirzepatide in weight loss, diabetes prevention and prevention of obesity-related complications for adults with obesity.

Mayor of Greater Manchester, Andy Burnham, said: ‘Greater Manchester is world-renowned as a hub for innovation in health and life sciences. The results of the trial announced today could have a far-reaching impact on how we treat obesity globally, and our city-region is ready to make a significant contribution through our outstanding health data assets, R&D expertise, and the strong partnerships between industry, universities and public sector organisations.'

The five-year study will also aim to collect data on healthcare resource utilisation, health-related quality of life and changes in participants' employment status and sick days from work.

Greater Manchester awarded for pioneering smoke-free programme

Greater Manchester awarded for pioneering smoke-free programme

By Lee Peart 27 March 2025

Greater Manchester has been recognised for its pioneering work on creating a smoke-free city with an international award.

Chancellor's benefits changes prompt concern

By Liz Wells 26 March 2025

Chancellor Rachel Reeves has confirmed a huge shake-up to Universal Credit, the eligibility criteria for Personal Independence Payments and a raft of other m...

Think-tank calls for 'radical health devolution'

By Lee Peart 25 March 2025

A think-tank has called for radical health devolution as a precursor to building a Neighbourhood Health Service.


Popular articles by Lee Peart